Cargando…
The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia
INTRODUCTION: Early infant diagnosis (EID) and treatment can prevent much of the HIV-related morbidity and mortality experienced by children but is challenging to implement in sub-Saharan Africa. Point-of-care (PoC) testing would decentralize testing and increase access to rapid diagnosis. The objec...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943017/ https://www.ncbi.nlm.nih.gov/pubmed/33690733 http://dx.doi.org/10.1371/journal.pone.0248217 |
_version_ | 1783662415157657600 |
---|---|
author | De Broucker, Gatien Salvatore, Phillip P. Mutembo, Simon Moyo, Nkumbula Mutanga, Jane N. Thuma, Philip E. Moss, William J. Sutcliffe, Catherine G. |
author_facet | De Broucker, Gatien Salvatore, Phillip P. Mutembo, Simon Moyo, Nkumbula Mutanga, Jane N. Thuma, Philip E. Moss, William J. Sutcliffe, Catherine G. |
author_sort | De Broucker, Gatien |
collection | PubMed |
description | INTRODUCTION: Early infant diagnosis (EID) and treatment can prevent much of the HIV-related morbidity and mortality experienced by children but is challenging to implement in sub-Saharan Africa. Point-of-care (PoC) testing would decentralize testing and increase access to rapid diagnosis. The objective of this study was to determine the cost-effectiveness of PoC testing in Southern Province, Zambia. METHODS: A decision tree model was developed to compare health outcomes and costs between the standard of care (SoC) and PoC testing using GeneXpert and m-PIMA platforms. The primary health outcome was antiretroviral treatment (ART) initiation within 60 days of sample collection. Additional outcomes included ART initiation by 12 months of age and death prior to ART initiation. Costs included both capital and recurrent costs. Health outcomes and costs were combined to create incremental cost effectiveness ratios (ICERs). RESULTS: The proportion of children initiating ART within 60 days increased from 27.8% with SoC to 79.8–82.8% with PoC testing depending on the algorithm and platform. The proportion of children initiating ART by 12 months of age increased from 50.9% with SoC to 84.0–86.5% with PoC testing. The proportion of HIV-infected children dying prior to ART initiation decreased from 18.1% with SoC to 3.8–4.6% with PoC testing. Total program costs were similar for the SoC and GeneXpert but higher for m-PIMA. ICERs for PoC testing were favorable, ranging from $23–1,609 for ART initiation within 60 days, $37–2,491 for ART initiation by 12 months of age, and $90–6,188 for deaths prior to ART initiation. Factors impacting the costs of PoC testing, including the lifespan of the testing instruments and integrated utilization of PoC platforms, had the biggest impact on the ICERs. Integrating utilization across programs decreased costs for the EID program, such that PoC testing was cost-saving in some situations. CONCLUSION: PoC testing has the potential to improve linkage to care and ART initiation for HIV-infected infants and should be considered for implementation within EID programs to achieve equity in access to HIV services and reduce HIV-related pediatric morbidity and mortality. |
format | Online Article Text |
id | pubmed-7943017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-79430172021-03-19 The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia De Broucker, Gatien Salvatore, Phillip P. Mutembo, Simon Moyo, Nkumbula Mutanga, Jane N. Thuma, Philip E. Moss, William J. Sutcliffe, Catherine G. PLoS One Research Article INTRODUCTION: Early infant diagnosis (EID) and treatment can prevent much of the HIV-related morbidity and mortality experienced by children but is challenging to implement in sub-Saharan Africa. Point-of-care (PoC) testing would decentralize testing and increase access to rapid diagnosis. The objective of this study was to determine the cost-effectiveness of PoC testing in Southern Province, Zambia. METHODS: A decision tree model was developed to compare health outcomes and costs between the standard of care (SoC) and PoC testing using GeneXpert and m-PIMA platforms. The primary health outcome was antiretroviral treatment (ART) initiation within 60 days of sample collection. Additional outcomes included ART initiation by 12 months of age and death prior to ART initiation. Costs included both capital and recurrent costs. Health outcomes and costs were combined to create incremental cost effectiveness ratios (ICERs). RESULTS: The proportion of children initiating ART within 60 days increased from 27.8% with SoC to 79.8–82.8% with PoC testing depending on the algorithm and platform. The proportion of children initiating ART by 12 months of age increased from 50.9% with SoC to 84.0–86.5% with PoC testing. The proportion of HIV-infected children dying prior to ART initiation decreased from 18.1% with SoC to 3.8–4.6% with PoC testing. Total program costs were similar for the SoC and GeneXpert but higher for m-PIMA. ICERs for PoC testing were favorable, ranging from $23–1,609 for ART initiation within 60 days, $37–2,491 for ART initiation by 12 months of age, and $90–6,188 for deaths prior to ART initiation. Factors impacting the costs of PoC testing, including the lifespan of the testing instruments and integrated utilization of PoC platforms, had the biggest impact on the ICERs. Integrating utilization across programs decreased costs for the EID program, such that PoC testing was cost-saving in some situations. CONCLUSION: PoC testing has the potential to improve linkage to care and ART initiation for HIV-infected infants and should be considered for implementation within EID programs to achieve equity in access to HIV services and reduce HIV-related pediatric morbidity and mortality. Public Library of Science 2021-03-09 /pmc/articles/PMC7943017/ /pubmed/33690733 http://dx.doi.org/10.1371/journal.pone.0248217 Text en © 2021 De Broucker et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article De Broucker, Gatien Salvatore, Phillip P. Mutembo, Simon Moyo, Nkumbula Mutanga, Jane N. Thuma, Philip E. Moss, William J. Sutcliffe, Catherine G. The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia |
title | The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia |
title_full | The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia |
title_fullStr | The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia |
title_full_unstemmed | The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia |
title_short | The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia |
title_sort | cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of hiv in southern zambia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943017/ https://www.ncbi.nlm.nih.gov/pubmed/33690733 http://dx.doi.org/10.1371/journal.pone.0248217 |
work_keys_str_mv | AT debrouckergatien thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT salvatorephillipp thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT mutembosimon thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT moyonkumbula thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT mutangajanen thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT thumaphilipe thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT mosswilliamj thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT sutcliffecatherineg thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT debrouckergatien costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT salvatorephillipp costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT mutembosimon costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT moyonkumbula costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT mutangajanen costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT thumaphilipe costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT mosswilliamj costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia AT sutcliffecatherineg costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia |